Funder
Pharmaceutical Research and Manufacturers of America Foundation
University of Colorado School of Medicine, Anschutz Medical Campus
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Health Policy,Pharmacology
Reference36 articles.
1. Diaby V, Ali A, Montero A. Value assessment frameworks in the United States: a call for patient engagement. Pharmacoecon Open. 2018;3(1):1–3.
2. Neumann P, Willke R, Garrison L. A health economics approach to US value assessment frameworks: introduction: an ISPOR Special Task Force Report [1]. Value Health. 2016;21(2):119–23.
3. Institute for Clinical and Economic Review. ICER 2020–2023 value assessment framework. 2020. https://icer.org/wp-content/uploads/2020/10/ICER_2020_2023_VAF_102220.pdf. Accessed 17 Jan 2021.
4. Lakdawalla D, Doshi J, Garrison L, Phelps C, Basu A, Danzon P. Defining elements of value in health care: a health economics approach: an ISPOR Special Task Force Report [3]. Value Health. 2018;21(2):131–9.
5. dosReis S, Butler B, Caicedo J, Kennedy A, Hong YD, Zhang C, et al. Stakeholder-engaged derivation of patient-informed value elements. Patient. 2020;13(5):611–21.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献